Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Clinical and Experimental Immunology
|
October 15, 2015
Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes
M J Haller, M A Atkinson, C H Wasserfall, et al.
Clinical and Experimental Immunology
|
September 2, 2008
Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice
Y Lu, M Parker, A Pileggi, et al.
Neurology
|
February 25, 2005
Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease
D Ramirez-Montealegre, S Chattopadhyay, T M Curran, et al.
The American Journal of Medicine
|
April 1, 1981
Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients
R W Haley, T M Hooton, D H Culver, et al.
Vascular Pharmacology
|
October 13, 2006
The application of genomic and proteomic technologies in predictive, preventive and personalized medicine
C D Collins, S Purohit, R H Podolsky, et al.
The Journal of Clinical Investigation
|
August 17, 1999
Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus
S A Litherland, X T Xie, A D Hutson, et al.
Journal of Autoimmunity
|
May 20, 1999
Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives
N Maclaren, M Lan, R Coutant, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
April 30, 2011
Country-specific birth weight and length in type 1 diabetes high-risk HLA genotypes in combination with prenatal characteristics
Y Sterner, C Törn, H-S Lee, et al.
Pediatric Diabetes
|
December 6, 2003
Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset
S A Litherland, J X She, D Schatz, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Clinical and Experimental Immunology
|
October 15, 2015
Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes
M J Haller, M A Atkinson, C H Wasserfall, et al.
Clinical and Experimental Immunology
|
September 2, 2008
Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice
Y Lu, M Parker, A Pileggi, et al.
Neurology
|
February 25, 2005
Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease
D Ramirez-Montealegre, S Chattopadhyay, T M Curran, et al.
The American Journal of Medicine
|
April 1, 1981
Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients
R W Haley, T M Hooton, D H Culver, et al.
Vascular Pharmacology
|
October 13, 2006
The application of genomic and proteomic technologies in predictive, preventive and personalized medicine
C D Collins, S Purohit, R H Podolsky, et al.
The Journal of Clinical Investigation
|
August 17, 1999
Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus
S A Litherland, X T Xie, A D Hutson, et al.
Journal of Autoimmunity
|
May 20, 1999
Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives
N Maclaren, M Lan, R Coutant, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association
|
April 30, 2011
Country-specific birth weight and length in type 1 diabetes high-risk HLA genotypes in combination with prenatal characteristics
Y Sterner, C Törn, H-S Lee, et al.
Pediatric Diabetes
|
December 6, 2003
Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset
S A Litherland, J X She, D Schatz, et al.
Page
of 6